bf/NASDAQ:GOVX_icon.jpeg

NASDAQ:GOVX

GeoVax Labs, Inc.

  • Stock

USD

Last Close

0.52

06/11 22:04

Market Cap

8.09M

Beta: 3.00

Volume Today

266.80K

Avg: 341.24K

PE Ratio

−2.88

PFCF: −0.23

    Description

    GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -800000-600000-400000-2000002018-08-072020-03-242022-03-092024-02-292024-11-12

    Revenue (Estimate*)

    500K1M1.50M2M2018-08-072020-03-242022-03-092024-02-292024-11-12

    *Estimate based on analyst consensus